{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-067133","form_type":"8-K","ticker":"RYTM","cik":"0001649904","company_name":"RHYTHM PHARMACEUTICALS, INC.","filed_at":"2025-07-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.561988+00:00","generated_at":"2026-05-18T06:56:22.126384+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Rhythm Pharmaceuticals raises $188.7M in public equity offering; underwriters exercise full option","bullets":["Offering of 2,058,824 shares at $85.00 per share; underwriters exercised 30-day option for 308,823 additional shares in full.","Net proceeds expected to be approximately $188.7 million after underwriting discounts and expenses.","Proceeds to advance clinical development of product candidates and commercialization activities for IMCIVREE, plus working capital.","Company believes cash and short-term investments, including offering net proceeds, will fund operations for at least 24 months.","Underwriting agreement with Morgan Stanley and BofA Securities as representatives of the underwriters."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-067133","json":"https://secwatch.observer/filing/0001104659-25-067133.json","markdown":"https://secwatch.observer/filing/0001104659-25-067133.md","text":"https://secwatch.observer/filing/0001104659-25-067133.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649904/000110465925067133/0001104659-25-067133-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649904/000110465925067133/tm2520063d4_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:56:22.126384+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}